UNITED THERAPEUTICS Corp

UTHR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001231589-26-000006
Filing date: Mar 5, 2026
Earliest execution date: Mar 5, 2026

Summary

Type

Sell

Net shares

-8,300

% of shares

-18.39%

Amount (USD)

$4,010,187

Insider confidence score

18.8 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Massive scheduled sell (<20% of shares)
  • Very large sell amount ($1M+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-05

Code

M

Net shares

+8,300.0

Price per Share

$146.03

Amount (USD)

$1,212,049.00

Acquired/Disposed

Acquired

Shares Owned Before

36,844.0

Shares Owned After

45,144.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-368.0

Price per Share

$479.43

Amount (USD)

$176,429.17

Acquired/Disposed

Disposed

Shares Owned Before

45,144.0

Shares Owned After

44,776.0

Transaction 3

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-1,602.0

Price per Share

$480.22

Amount (USD)

$769,310.20

Acquired/Disposed

Disposed

Shares Owned Before

44,776.0

Shares Owned After

43,174.0

Transaction 4

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-720.0

Price per Share

$481.33

Amount (USD)

$346,559.18

Acquired/Disposed

Disposed

Shares Owned Before

43,174.0

Shares Owned After

42,454.0

Transaction 5

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-1,177.0

Price per Share

$482.68

Amount (USD)

$568,114.48

Acquired/Disposed

Disposed

Shares Owned Before

42,454.0

Shares Owned After

41,277.0

Transaction 6

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-1,086.0

Price per Share

$483.54

Amount (USD)

$525,123.46

Acquired/Disposed

Disposed

Shares Owned Before

41,277.0

Shares Owned After

40,191.0

Transaction 7

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-1,398.0

Price per Share

$484.55

Amount (USD)

$677,402.58

Acquired/Disposed

Disposed

Shares Owned Before

40,191.0

Shares Owned After

38,793.0

Transaction 8

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-1,006.0

Price per Share

$485.32

Amount (USD)

$488,235.54

Acquired/Disposed

Disposed

Shares Owned Before

38,793.0

Shares Owned After

37,787.0

Transaction 9

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-743.0

Price per Share

$486.52

Amount (USD)

$361,482.13

Acquired/Disposed

Disposed

Shares Owned Before

37,787.0

Shares Owned After

37,044.0

Transaction 10

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-200.0

Price per Share

$487.65

Amount (USD)

$97,530.40

Acquired/Disposed

Disposed

Shares Owned Before

37,044.0

Shares Owned After

36,844.0

Derivative Transactions

Transaction 1

Security

Stock Option

Action

Exercise

Date

2026-03-05

Code

M

Net shares

-8,300.0

Acquired/Disposed

Disposed

Shares Owned Before

41,800.0

Shares Owned After

33,500.0

Filing's footnotes

1. This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

2. This transaction was executed in multiple trades at prices ranging from $486.41 to $486.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $487.475 to $487.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. Includes 63 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan.

5. This transaction was executed in multiple trades at prices ranging from $478.82 to $479.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. This transaction was executed in multiple trades at prices ranging from $479.82 to $480.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. This transaction was executed in multiple trades at prices ranging from $481.02 to $481.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. This transaction was executed in multiple trades at prices ranging from $482.025 to $482.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

9. This transaction was executed in multiple trades at prices ranging from $483.07 to $484.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

10. This transaction was executed in multiple trades at prices ranging from $484.07 to $484.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

11. This transaction was executed in multiple trades at prices ranging from $485.10 to $485.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.